title: The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers.
abstract: Germline mutations in the gene encoding the tumour suppressor E-cadherin (CDH1) are the underlying genetic defect responsible for hereditary diffuse gastric cancer (HDGC). A remarkably high percentage ( approximately 80%) of CDH1 mutations in HDGC patients and carriers generate premature termination codons (PTCs). Here, we examined whether CDH1 transcripts harbouring PTCs are downregulated by nonsense-mediated decay (NMD), an RNA surveillance pathway that degrades PTC-bearing transcripts. Using an allele-specific expression (ASE) assay to differentiate between mutated and wild-type CDH1 alleles, we found that PTC-bearing CDH1 mRNAs are strongly downregulated in normal gastric tissue from several CDH1 mutation carriers. We show that NMD is responsible for this robust downregulation, as CDH1 transcripts harbouring PTCs in the KATO-III gastric tumour cell line were upregulated in response to protein synthesis inhibitors or depletion of the NMD factors UPF1 and eIF4AIII. Analysis of HDGC patients harbouring CDH1 alleles with PTCs at a wide variety of different positions indicates an association of their predicted ability to induce NMD and an earlier age of onset of gastric cancer. This suggests that NMD may be detrimental for HDGC patients and therefore NMD is a potentially useful therapeutic target for CDH1 mutation carriers.
authors.affiliation: Cancer Genetics Group, Institute of Molecular Pathology and Immunology, University of Porto (IPATIMUP), Porto, Portugal.
authors.forename: R
authors.initials: R
authors.lastname: Karam
authors.forename: J
authors.initials: J
authors.lastname: Carvalho
authors.forename: I
authors.initials: I
authors.lastname: Bruno
authors.forename: C
authors.initials: C
authors.lastname: Graziadio
authors.forename: J
authors.initials: J
authors.lastname: Senz
authors.forename: D
authors.initials: D
authors.lastname: Huntsman
authors.forename: F
authors.initials: F
authors.lastname: Carneiro
authors.forename: R
authors.initials: R
authors.lastname: Seruca
authors.forename: M F
authors.initials: MF
authors.lastname: Wilkinson
authors.forename: C
authors.initials: C
authors.lastname: Oliveira
mesh_terms: D000328:Adult; D017668:Age of Onset; D000368:Aged; D015703:Antigens, CD; D001483:Base Sequence; D015820:Cadherins / Q000235:genetics* / Q000378:metabolism; D018389:Codon, Nonsense / Q000235:genetics / Q000502:physiology; D015536:Down-Regulation; D039601:Eukaryotic Initiation Factor-4A / Q000235:genetics / Q000502:physiology; D018095:Germ-Line Mutation; D006579:Heterozygote; D006801:Humans; D008875:Middle Aged; D020365:RNA Helicases; D020871:RNA Stability / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013274:Stomach Neoplasms / Q000235:genetics* / Q000378:metabolism; D015534:Trans-Activators / Q000235:genetics / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: D015703:Antigens, CD; C513384:CDH1 protein, human; D015820:Cadherins; D018389:Codon, Nonsense; D012333:RNA, Messenger; D015534:Trans-Activators; D039601:Eukaryotic Initiation Factor-4A; D020365:RNA Helicases; C101828:UPF1 protein, human